Company: TXG
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001770787-25-000018
Chunk: 80

Company: 10x Genomics, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 80
---
3) Consists of (a) 39,005 shares of Class A common stock held directly by Dr. Hindson, (b) 200,584 shares of Class A common stock issuable pursuant to stock options exercisable within 60 days of March 31, 2025, (c) 20,654 shares of Class A common stock issuable pursuant to restricted stock units vesting within 60 days of March 31, 2025, (d) 2,733,000 shares of Class B common stock held by the Hindson Family Revocable Trust of which Dr. Hindson serves as trustee, (e) 133,500 shares of Class B common stock held by the Hindson Descendants Irrevocable Trust FBO BLH of which Dr. Hindson serves as trustee and (f) 133,500 shares of Class B common stock held by the Hindson Descendants Irrevocable Trust FBO BAH of which Dr. Hindson serves as trustee.

(4) Consists of (a) 128,114 shares of Class A common stock held directly by Mr. Whitaker, (b) 343,401 shares of Class A common stock issuable pursuant to stock options exercisable within 60 days of March 31, 2025, (c) 29,027 shares of Class A common stock issuable pursuant to restricted stock units vesting within 60 days of March 31, 2025, (d) 21,470 shares of Class A common stock held by Eric Whitaker Exempt 2020 Trust, (e) 21,470 shares of Class A common stock held by Sandra Gross Exempt 2020 Trust and (f) 2,121 shares of Class A common stock held by Whitaker-Gross Living Trust of which Mr. Whitaker serves as trustee.

(5) Consists of (a) 352,087 shares of Class A common stock held directly by Dr. Stuelpnagel, (b) 15,956 shares of Class A common stock issuable pursuant to stock options exercisable within 60 days of March 31, 2025, (c) 2,163 shares of Class A common stock issuable pursuant to restricted stock units vesting within 60 days of March 31, 2025 and (d) 2,105,736 shares of Class B common stock held by the John R. Stuelpnagel Trust